- Home
- CRVO vs JFU Comparison
CRVO vs JFU Comparison
Compare CRVO & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRVO | JFU |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 54.5M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CRVO | JFU |
|---|---|---|
| Price | $4.00 | $4.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | ★ 79.7K | 5.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,737,974.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | ★ 36.29 | N/A |
| 52 Week Low | $1.92 | $1.01 |
| 52 Week High | $16.50 | $9.48 |
Technical Indicators
Market Signals| Indicator | CRVO | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 32.65 | 41.42 |
| Support Level | N/A | $4.12 |
| Resistance Level | $5.44 | $5.66 |
| Average True Range (ATR) | 0.43 | 0.38 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 23.35 | 10.49 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.